Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
about
Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis.Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.Minimal Change Disease.Clinical trials in minimal change disease.
P2860
Q30240107-3E02100B-DBBF-4A29-A31E-5D7505796CEAQ38842494-B1CF91A4-6AF0-4EAC-ADF1-6D8888781618Q38895019-C240FB87-5851-4859-A921-0B96EB2072E4Q39440837-ED9C4DE7-18A2-49F3-A18C-715C246941B5Q51097707-7879C030-D744-4A95-AEE2-9F816F9555F3Q52945061-50A4A12C-AC95-4788-94A1-115A8A7FC5FFQ53368686-4A0DEB50-53BA-4AFA-9037-39E264EFBA04
P2860
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cyclophosphamide and rituximab ...... -dependent nephrotic syndrome.
@en
type
label
Cyclophosphamide and rituximab ...... -dependent nephrotic syndrome.
@en
prefLabel
Cyclophosphamide and rituximab ...... -dependent nephrotic syndrome.
@en
P2093
P2860
P1433
P1476
Cyclophosphamide and rituximab ...... d-dependent nephrotic syndrome
@en
P2093
Detlef Bockenhauer
Graciana Jaureguiberry
Hazel Webb
Kjell Tullus
P2860
P2888
P304
P356
10.1007/S00467-015-3245-9
P577
2015-11-02T00:00:00Z
P5875
P6179
1000990705